Etamicastat, also known as BIA 5-453, is a potent, reversible, peripherally selective dopamine -hydroxylase inhibitor (DBH inhibitor). Chronic dopamine ß-hydroxylase inhibition with etamicastat effectively decreases blood pressure, although does not prevent the development of hypertension in the spontaneously hypertensive rat.
仅供研究使用。 我们不向患者出售。
化学信息
| 名称 | Etamicastat HCl salt |
| Iupac 化学名称 | (R)-5-(2-aminoethyl)-1-(6,8-difluorochroman-3-yl)-1,3-dihydro-2H-imidazole-2-thione hydrochloride |
| 同义词 | BIA 5-453; BIA5-453 |
| 英文同义词 | BIA 5-453; BIA5-453 |
| 分子式 | C14H16ClF2N3OS |
| 分子量 | 347.8088 |
| Smile | Cl.NCCC1=CNC(N1[C@H]1COC2=C(C=C(C=C2C1)F)F)=S |
| InChiKey | CKRDOSZCFINPAD-RFVHGSKJSA-N |
| InChi | InChI=1S/C14H15F2N3OS.ClH/c15-9-3-8-4-11(7-20-13(8)12(16)5-9)19-10(1-2-17)6-18-14(19)21;/h3,5-6,11H,1-2,4,7,17H2,(H,18,21);1H/t11-;/m1./s1 |
| Cas号 | 677773-32-9 |
| 相关CAS号 | |
| 外观性状 | Solid powder |
| 纯度 | 98% by HPLC |
| 存储 | -20 ºC for 3 years |
| 可溶性 | Soluble in DMSO |
| 处理方式 | |
| 运输条件 | Shipped under ambient temperature |
| 海关编码 | |
| Targets | |
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study | |